XML 98 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 29, 2019
Dec. 30, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net loss $ (15,444,000) $ (13,779,000) $ (14,131,000)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 1,201,000 1,276,000 1,373,000
Stock-based compensation 3,144,000 1,901,000 1,441,000
Write-down of inventories 94,000 386,000 232,000
Write-off of equipment 4,000 5,000 12,000
Tax benefit from acquisition (185,000)    
Gain on disposal of assets   (62,000)  
Changes in operating assets and liabilities:      
Accounts receivable 218,000 (1,284,000) (86,000)
Inventories 483,000 (662,000) (1,774,000)
Other assets 229,000 (879,000) 103,000
Trade payables (456,000) 223,000 (145,000)
Accrued liabilities (1,024,000) 235,000 72,000
Deferred income 158,000    
Other long-term liabilities (16,000) 2,000 (35,000)
Net cash used in operating activities (11,594,000) (12,638,000) (12,938,000)
Cash flows from investing activities:      
Capital expenditures for property and equipment (576,000) (351,000) (642,000)
Capitalized internal-use software (365,000)    
Cash received from business acquisition 20,000    
Proceeds from sale of assets   63,000  
Net cash used in investing activities (921,000) (288,000) (642,000)
Cash flows from financing activities:      
Payment of finance lease obligations (365,000) (407,000) (344,000)
Proceeds from line of credit 46,000,000 36,000,000 18,000,000
Repayment of line of credit (46,000,000) (27,000,000) (18,000,000)
Proceeds from issuance of common stock 9,437,000 16,215,000 17,550,000
Stock issuance costs (1,181,000) (1,638,000) (1,771,000)
Taxes paid related to net settlement of equity awards (291,000) (308,000) (198,000)
Net cash provided by financing activities 7,600,000 22,862,000 15,237,000
Net (decrease) increase in cash, cash equivalents and restricted cash (4,915,000) 9,936,000 1,657,000
Cash, cash equivalents and restricted cash at the beginning of the period 26,463,000 16,527,000 14,870,000
Cash, cash equivalents, and restricted cash at the end of the period 21,548,000 26,463,000 16,527,000
Supplemental disclosures of cash flow information:      
Interest paid 300,000 89,000 106,000
Income taxes paid 126,000 171,000 157,000
Supplemental schedule of non-cash investing and financing activities :      
Fair value of common stock issued as consideration for business acquisition 903,000    
Finance lease obligation to finance capital expenditures $ 471,000 424,000 654,000
Purchase of equipment included in accounts payable   $ 5,000 $ 436,000